 |
Hot Pursuit
27-Feb-24
|
|
|
|
|
|
|
|
|
|
|
|
Pfizer Ltd down for fifth straight session
|
|
Pfizer Ltd is quoting at Rs 4359.35, down 0.93% on the day as on 13:19 IST on the NSE. The stock gained for a third straight session today in last one year as compared to a 28.37% up 0.38%. in NIFTY and a 61.97% up 30.9% in the Nifty Pharma index.
|
|
|
|
|
|
Pfizer Ltd is down for a fifth straight session today. The stock is quoting at Rs 4359.35, down 0.93% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.41% on the day, quoting at 22212.3. The Sensex is at 73119.59, up 0.45%.Pfizer Ltd has added around 0.36% in last one month.Meanwhile, Nifty Pharma index of which Pfizer Ltd is a constituent, has increased around 7.96% in last one month and is currently quoting at 18956.45, up 0.37% on the day. The volume in the stock stood at 6122 shares today, compared to the daily average of 38388 shares in last one month. The PE of the stock is 39.62 based on TTM earnings ending December 23.
|
|
|
|
Previous News |
Pfizer Ltd soars 0.67%, gains for fifth straight session
(
Hot Pursuit
-
06-Oct-23
13:00
)
|
|
|
Pfizer
(
Results
-
Analysis
20-May-22
22:14
)
|
|
|
Pfizer Ltd soars 1.41%, Gains for third straight session
(
Hot Pursuit
-
28-Jul-23
13:05
)
|
|
|
Volumes soar at PNB Housing Finance Ltd counter
(
Hot Pursuit
-
30-Jul-24
11:00
)
|
|
|
Pfizer and Glenmark collaborate for launch of abrocitinib in India
(
Corporate News
-
31-Jan-24
17:35
)
|
|
|
Pfizer to conduct AGM
(
Corporate News
-
28-Jul-23
17:24
)
|
|
|
Pfizer Ltd drops for fifth straight session
(
Hot Pursuit
-
21-Oct-21
13:35
)
|
|
|
Pfizer Ltd up for fifth session
(
Hot Pursuit
-
12-Dec-23
13:00
)
|
|
|
Pfizer Q3 PAT up 5% YoY; board appoints Meenakshi Nevatia as MD
(
Hot Pursuit
-
10-Feb-23
09:58
)
|
|
|
Board of Pfizer recommends Special Dividend
(
Corporate News
-
16-May-23
11:01
)
|
|
|
Pfizer standalone net profit rises 25.10% in the March 2022 quarter
(
Results
-
Announcements
21-May-22
08:30
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|